Man performs a bodyweight squat in a home exercise space

Low Testosterone and Belly Fat: What the Link Means

Understand the link between low testosterone and belly fat, what studies actually measured, and which symptoms and test results to discuss with a clinician.

Low testosterone and belly fat are associated. Diagnosis requires symptoms, repeat morning tests and assessment of possible causes.

That distinction matters when you are deciding whether to change your health habits, discuss symptoms with a clinician or consider a treatment offer. Those are different decisions, and a photograph, waist measurement or single laboratory result cannot settle all three.

The useful starting point: Treat waist size as information about body composition and health risk, symptoms as information to discuss, and a testosterone result as something that needs clinical interpretation. None is a substitute for the others.

Hormone regulation and body fat can affect one another. Their relationship is not a fixed sequence in every man.

Obesity can accompany altered hormone signaling and testosterone-carrying proteins. A hormone disorder can affect body composition without explaining every waist change.

Endocrine Society patient guidance lists testicular or pituitary problems, medicines, chronic disease and sleep disorders. Illness, poor nutrition or excessive exercise can temporarily lower measurements.

This is why the same symptom can lead to different conclusions in different people. Replacing a broad claim that hormones caused your belly fat with a clinical assessment is more useful than trying to identify the cause from appearance.

Belly fat, visceral fat and waist size measure different things

Visceral fat is fat inside the abdomen around internal organs; subcutaneous fat is underneath the skin. The visible size of a belly does not show how much of each a person has.

A waist measurement records abdominal size. It can provide useful risk information, but it also reflects subcutaneous fat, muscle and body structure, so it is not a direct scan of visceral fat.

Body mass index, or BMI, relates weight to height without separating fat from muscle. Imaging methods can estimate fat distribution more directly, but the fact that a study used a scan does not mean every reader needs one.

The methods guide distinguishes these body compartments.

What each observation can and cannot answer
Observation Useful information What it cannot establish alone
Weight or BMI Body size and weight trends Exact fat distribution or hormone status
Waist circumference Abdominal size and a component of risk assessment A visceral-fat amount or diagnosis of low testosterone
A scan-derived visceral-fat estimate A more specific body-composition measurement Which condition came first or whether hormone treatment is indicated
One total-testosterone result The concentration measured in that sample A confirmed cause of symptoms or a treatment decision

NIDDK explains that abdominal size can add health-risk information even when BMI is not high. Its adult health guidance treats weight management as a broader health question involving food, activity, sleep, medicines and other circumstances.

What the studies actually show

Both 2026 papers used overlapping NHANES 2011 to 2016 data. They are cross-sectional comparisons, not independent replications.

Association studies and a small intervention answer different questions
Research People and measurements Finding and limit
Friedl and Potter, 2026 4,948 men aged 20 to 59; 4,492 had valid scan-derived visceral-fat measurements More visceral fat accompanied lower total testosterone, including among men in similar BMI categories. Cross-sectional data cannot identify the direction of cause.
Potter and Friedl, 2026 4,984 men aged 20 to 59; different analyses used available body-fat, visceral-fat or waist measurements Adiposity measures had stronger associations with testosterone than age alone; waist size performed comparably to scan-derived visceral fat. This did not test weight loss or diagnose participants clinically.
Rebuffé-Scrive and colleagues, 1991 A preliminary testosterone intervention; the abstract reports 11 examined middle-aged men Reported abdominal fat-metabolism changes and decreased waist/hip circumference in nine men. The abstract does not establish a quantified loss of visceral fat or a modern treatment plan.

The first 2026 analysis used DXA-derived estimates of visceral fat and a single morning testosterone sample. Its observation that men with similar BMI can differ in fat distribution helps explain why the scale alone is incomplete.

The second analysis lacked repeat hormone testing and comprehensive symptom assessment. Its biochemical threshold was not a clinical diagnosis of hypogonadism.

Neither measured a testosterone response to weight loss. Both excluded men older than 59, so they cannot settle later-life aging effects.

The 1991 study’s accessible abstract is useful as early intervention evidence, but its small, preliminary findings should not become a promise that testosterone will remove a reader’s belly fat. The abstract’s fat-metabolism measurements and circumference observations are different outcomes from a directly measured visceral-fat reduction.

Why one low number is not the whole diagnosis

Sex hormone-binding globulin, or SHBG, carries testosterone in blood. Changes in this protein can affect interpretation of total testosterone.

The Endocrine Society clinical guideline recommends diagnosing hypogonadism only when compatible symptoms or signs occur with unequivocally and consistently low testosterone. It calls for repeat morning fasting measurements using an accurate assay.

Near the lower total-testosterone limit or with altered SHBG, the guideline recommends appropriate free-testosterone assessment. Clinical interpretation cannot be replaced by an online reference range.

In its July 2026 statement, the Society reinforces that symptoms alone are not diagnostic and that reversible contributors such as obesity and certain medicines need evaluation. It does not support population-wide testosterone screening in men without symptoms.

Discuss persistent changes in sexual desire, erections or energy with a healthcare professional. Fatigue and mood changes have many causes; assessment should investigate them rather than assume a hormone diagnosis.

What exercise and nutrition can reasonably help

You do not need to prove a testosterone increase for physical activity to be worthwhile. CDC describes benefits for strength, daily function, blood pressure and blood-sugar management in its physical-activity guidance.

A systematic review of exercise training in men aged 60 or older found no significant overall increase in basal testosterone with resistance training. It included both randomized and uncontrolled studies, and results varied by training type and hormone measure.

That finding is about resting hormone measurements, not a verdict that strength training has no benefit. Feeling stronger, managing daily tasks better or improving a measured health risk can matter even when testosterone does not rise.

Man holds a dumbbell in a squat position beside another man in a gym
An illustrative strength session. Exercise can support strength and function while hormone symptoms receive a separate clinical assessment.

Choose activity you can perform comfortably and build it around your capacity, health conditions and preferences. If pain, unusual breathlessness or a medical limitation makes that difficult, ask your care team for an appropriate starting point instead of copying a demanding hormone-boosting workout.

Food choices and weight management also need context rather than a fixed protein, calorie or weight target for every man. For a diagnosed obesity-related hormone problem, the Endocrine Society describes addressing excess weight as typically first-line when no other cause has been identified.

Weight loss does not guarantee normalized testosterone. Ask which symptoms, metabolic-health measures and hormone results your clinician will follow.

A practical habit change might be making a comfortable activity easier to repeat or planning meals that provide a varied mix of nutrient-rich foods. The aim is a sustainable health plan; supplements and extreme restriction are not substitutes for an assessment.

Is testosterone therapy a belly-fat treatment?

Testosterone can affect body composition, but that does not make it an automatic treatment for abdominal fat. A prescription decision depends on a properly established diagnosis, its cause, symptoms, goals, risks and follow-up.

FDA says testosterone products are approved for men with low testosterone in conjunction with an associated medical condition. Its 2025 labeling update retained limitations for age-related hypogonadism and required blood-pressure warning changes.

The update also removed boxed-warning language about increased cardiovascular outcomes after the TRAVERSE findings. That change is not proof that therapy is risk-free or appropriate solely because a man’s waist has grown.

The guideline recommends against testosterone for blood-sugar control in men with type 2 diabetes. Hormone-disorder, diabetes and obesity care need coordinated decisions, rather than treating one hormone as a universal fix.

Discuss fertility plans and monitoring before treatment. If already prescribed testosterone, take concerns to your prescriber rather than changing the dose because of weight, a video or one result.

A useful record to take to an appointment

A short record can make the conversation more specific without turning it into a self-diagnosis. Use what you already know; the table is not an instruction to order a hormone panel or delay care until you have collected every item.

Separate the change, the measurement and the next question
What to note Helpful detail Question for your clinician
A persistent symptom What changed, when it began and how it affects daily life What possible causes should we evaluate?
A weight or waist trend Measurements already available and how they were taken How does this fit my broader metabolic risk?
Sleep, illness, medicines and supplements Recent changes and a complete current list Could these affect symptoms or test interpretation?
An existing hormone result Full report, units, reference range and collection time Does this need confirmation or additional interpretation?
A proposed treatment The diagnosis being treated and the outcome you hope to improve What benefit, risk, fertility implications and follow-up apply to me?

The first decision is what needs assessment, not which testosterone product or workout to buy. Ask which symptoms, measurements and health risks will be reviewed together and how you will know whether the plan is helping.

Common questions

Can belly size tell me whether my testosterone is low?

No. Waist size is not a hormone measurement, a diagnosis or an explanation of a symptom.

Does losing belly fat guarantee a testosterone increase?

No response is guaranteed: obesity can be reversible, while other causes need different care. These cross-sectional studies did not measure a fat-loss response.

Does this mean aging has no effect?

No. The studies cover ages 20 to 59, not every older man; they do not rule out aging effects.

Should every man with belly fat get a testosterone test?

The Endocrine Society recommends against routine general-population screening. Discuss persistent symptoms and your circumstances with a clinician, who can decide whether testosterone testing is appropriate.

Sources

  1. Friedl and Potter. Low testosterone is a phenotype of visceral adiposity. Journal of the Endocrine Society, 2026.
  2. Potter and Friedl. Adiposity, not chronological aging, is the dominant determinant of circulating testosterone in US adult men. Journal of the Endocrine Society, 2026.
  3. Rebuffé-Scrive and colleagues. Effect of testosterone on abdominal adipose tissue in men. International Journal of Obesity, 1991; abstract.
  4. Endocrine Society. Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline, 2018; Statement on Testosterone Replacement Therapy, July 2026; and Hypogonadism in Men, patient guidance.
  5. Hayes and Elliott. Short-Term Exercise Training Inconsistently Influences Basal Testosterone in Older Men. Frontiers in Physiology, 2019.
  6. CDC. Benefits of Physical Activity.
  7. NIDDK. Health Tips for Adults.
  8. FDA. Class-wide labeling changes for testosterone products, 2025.
  9. Prado and colleagues. Body-composition assessment methods guide. American Journal of Clinical Nutrition, 2026.

Medical disclaimer: This article provides general health and fitness information, not medical advice or an individualized diagnosis, treatment, exercise or nutrition plan. If you have persistent symptoms, an injury or a medical condition, ask a qualified healthcare professional which assessments and activities are appropriate for you.

Share your love
Chris Pruitt, certified personal trainer and WorkoutHealthy founder
Chris Pruitt

Chris Pruitt is a certified ASFA personal trainer and the founder of WorkoutHealthy, a fitness equipment retailer serving customers since 2007. He has more than 16 years in the fitness business, and he writes and fact checks everything published on Insider.

The Insider Five

Five stories worth your time, every Friday. One email a week, no pitches.